-

Everleap Expands Fertility Care in New Jersey with New Clinic in Paramus

Full-Service Clinic Brings Advanced Fertility Care Closer to Patients in North Jersey

PARAMUS, N.J.--(BUSINESS WIRE)--Everleap Fertility, a U.S. leader in fertility care formerly known as RMA New Jersey and part of IVI Institute, the global leader in reproductive medicine, announced the opening of Everleap Fertility Paramus, a new clinic that provides greater access to care for those living and working in the North Jersey community. The full-service facility, located at 650 From Road, Suite 260, is Everleap Fertility’s twelfth location in New Jersey.

“We’re thrilled to further expand Everleap Fertility’s presence across New Jersey and bring advanced fertility care closer to patients in Paramus,” said Dr. Marcy Maguire, Everleap Fertility New Jersey Clinical Director.

Share

“We’re thrilled to further expand Everleap Fertility’s presence across New Jersey and bring advanced fertility care closer to patients in Paramus,” said Dr. Marcy Maguire, Everleap Fertility New Jersey Clinical Director. “We are committed to increasing access to much-needed care in communities like Paramus across the state to help New Jerseyans realize their family-building dreams.”

Everleap Fertility offers a wide range of fertility treatments including IVF, intrauterine insemination (IUI), preimplantation genetic testing (PGT), egg freezing, and donor egg, sperm, and gestational surrogacy services for every stage of patients’ fertility journeys. It also offers family planning resources and options for LGBTQ+ individuals and fertility preservation treatments for those with autoimmune diseases or cancer diagnoses.

Based on US findings from the IVI Institute Fertility Barometer, becoming a mother is an important life goal for most women—more than half of those surveyed describe it as one of their highest personal priorities. However, the study also shows that infertility is far more common than many people assume. One in five US women aged 19–49 report having experienced infertility at some point in their lives—and for many women, the decision to pursue fertility treatment is complex. Among the perceived barriers to treatment, nearly 38% cited waiting lists and distance to clinics.

“It’s exciting to bring this practice to life alongside our lead physicians and work together to build a strong, collaborative team rooted in clinical excellence and compassionate patient care,” added Dr. Maria Costantini-Ferrando, Everleap Fertility East Coast Regional Medical Director. “We have created an environment in Paramus where patients can feel supported, informed, and confident in their treatment, and we look forward to delivering the excellent patient experience and industry-leading outcomes that Everleap Fertility is known for.”

Everleap Fertility – Paramus is open and scheduling new patient visits. Appointments can be made by calling the office at 281-747-6595 or by visiting https://www.everleapfertility.com/request-an-appointment.

About Everleap Fertility
Built on the legacy of RMA, Boston IVF, Conceptions, and six other leading North American fertility practices, Everleap Fertility brings together physicians and embryologists across 65+ locations in the U.S., including 25 IVF laboratories focused on the next leap forward in reproductive medicine. Together, we have helped hundreds of thousands of patients build families for more than 40 years. As part of IVI Institute, Everleap Fertility contributes to a global community working together to advance the field and bring progress in reproductive medicine into patient care. For more information, visit everleapfertility.com.

About IVI Institute
IVI Institute is the global leader in reproductive medicine, bringing together world-class fertility clinics and expertise to advance the future of fertility care around the world. With 100+ babies born every day across more than 200 locations in 15 countries – including IVI Fertility, Everleap Fertility, LIVIO, Create Fertility, and TRIO clinics, among other brands – IVI Institute accelerates innovation, expands knowledge, and improves outcomes for patients around the world through groundbreaking research, collaboration, and rigorous clinical standards. Learn more at www.iviinstitute.com.

Contacts

Media Contact
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

Everleap Fertility


Release Versions

Contacts

Media Contact
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

More News From Everleap Fertility

Everleap Expands Fertility Care in Greater Houston Metropolitan Area with New Clinic in The Woodlands, Texas

THE WOODLANDS, Texas--(BUSINESS WIRE)--Everleap Fertility, a U.S. leader in fertility care formerly known as RMA Houston, and part of IVI Institute, the global leader in reproductive medicine, announced the opening of Everleap Fertility The Woodlands, a new clinic that provides greater access to care for those living and working in the Northern Houston suburban community. The full-service facility, located at 9303 New Trails Drive, Suite 100, is Everleap Fertility’s second location in Texas. “T...

Reproductive Endocrinologist and Former RMA Fellow Dr. Francesca Barrett and Reproductive Surgeon Dr. Chelsea Manning Join Everleap Fertility, Expanding Fertility Care in New Jersey

BASKING RIDGE, N.J. & MORRISTOWN, N.J.--(BUSINESS WIRE)--Everleap Fertility, a leader in fertility care and assisted reproduction, formerly known as IVI RMA North America, announced today that Dr. Francesca Barrett, a reproductive endocrinologist and infertility specialist, and Dr. Chelsea Manning, a reproductive surgeon, have joined the New Jersey care team at Everleap Fertility. Dr. Manning is now seeing patients at Everleap Fertility, Basking Ridge, Everleap’s flagship clinic, located at 140...

Everleap Fertility Researcher Receives 2026 ASRM Nurse Professional Group Prize Paper Award for Study on Obesity and Embryonic Aneuploidy

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Everleap Fertility, a U.S. leader in fertility care formerly known as IVI RMA North America, part of IVI Institute, the global leader in reproductive medicine, announced that its research examining obesity's impact on embryonic aneuploidy in IVF patients won the 2026 Nurses Professional Group Prize Paper Award at the American Society for Reproductive Medicine (ASRM) 2026 Annual Scientific Congress & Expo. Presented annually at ASRM, the award recognizes...
Back to Newsroom